OrthAlign Receives 510(k) FDA Clearance for ORTHALIGN PLUS System

OrthAlign, a privately held medical device company, announced it has received 510(k) clearance from the United States Food and Drug Administration to market its ORTHALIGN PLUS system.

Advertisement

The computer-controlled system is a palm-sized, single-use navigation device for total hip arthroplasty (both anterior and posterior approaches) and total knee arthroplasty surgeries.

More Articles on Devices:  

FDA Clears Renovis Surgical’s Tesera Anterior Lumbar Interbody Fusion Cage
Device Companies — 7 Key Notes — Biomet, MAKO Surgical & More
46 Spine & Orthopedic Devices Receive FDA 510(k) Clearance in October

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.